Evolent Health Inc [EVH] stock Initiated by Citigroup analyst, price target now $40

Evolent Health Inc [NYSE: EVH] loss -2.10% on the last trading session, reaching $19.58 price per share at the time.

If compared to the average trading volume of 1.47M shares, EVH reached a trading volume of 6216477 in the most recent trading day, which is why market watchdogs consider the stock to be active.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Here is what top equities market gurus are saying about Evolent Health Inc [EVH]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EVH shares is $41.36 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EVH stock is a recommendation set at 1.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Citigroup have made an estimate for Evolent Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 22, 2024. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on March 01, 2024, representing the official price target for Evolent Health Inc stock. Previously, the target price had yet another raise to $39, while Barclays analysts kept a Overweight rating on EVH stock.

The Average True Range (ATR) for Evolent Health Inc is set at 0.96, with the Price to Sales ratio for EVH stock in the period of the last 12 months amounting to 1.05. The Price to Book ratio for the last quarter was 2.14, with the Price to Cash per share for the same quarter was set at 1.87. Price to Free Cash Flow for EVH in the course of the last twelve months was 17.45 with Quick ratio for the last quarter at 1.02.

Trading performance analysis for EVH stock

Evolent Health Inc [EVH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.41. With this latest performance, EVH shares dropped by -14.87% in over the last four-week period, additionally sinking by -40.10% over the last 6 months – not to mention a drop of -32.46% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EVH stock in for the last two-week period is set at 35.59, with the RSI for the last a single of trading hit 36.94, and the three-weeks RSI is set at 34.82 for Evolent Health Inc [EVH]. The present Moving Average for the last 50 days of trading for this stock 23.24, while it was recorded at 19.40 for the last single week of trading, and 28.24 for the last 200 days.

Evolent Health Inc [EVH]: A deeper dive into fundamental analysis

Evolent Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.02 and a Current Ratio set at 1.02.

Evolent Health Inc [EVH]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EVH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Evolent Health Inc go to 30.00%.

An analysis of Institutional ownership at Evolent Health Inc [EVH]

The top three institutional holders of EVH stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in EVH stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in EVH stock with ownership which is approximately 5.1238%.

Most Popular